Terrie Curran - 11 Nov 2024 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role: Director
Signature: /s/ David Topper, as Attorney-in-Fact for Terrie Curran
Issuer symbol: ARQT
Transactions as of: 11 Nov 2024
Net transactions value: -$94,238
Form type: 4
Filing time: 13 Nov 2024, 18:45:09 UTC
Previous filing: 17 Jul 2024
Next filing: 23 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARQT	Common Stock	Sale	$94,238	-8,687	-46%	$10.85	10,139	11 Nov 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $10.7542 to $10.97, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $10.7542 to $10.97, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.